us en false false Default
Skip directly to Accessibility Notice
PPH VanEck Pharmaceutical ETF Please read important disclosure Close important disclosure false

PPH
VanEck Pharmaceutical ETF

PPH
VanEck Pharmaceutical ETF

  • NAV
    $111.70

    as of February 27, 2026
  • YTD RETURNS
    8.32%

    as of February 27, 2026
  • Total Net Assets
    $1.31B

    as of February 27, 2026
  • Total Expense Ratio
    0.36%
  • Inception Date
    12/20/2011

About PPH

VanEck Pharmaceutical ETF (PPH®) seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS® US Listed Pharmaceutical 25 Index (MVPPHTR), which is intended to track the overall performance of companies involved in pharmaceuticals, including pharmaceutical research and development as well a production, marketing and sales of pharmaceuticals.

Buy Now
Let's Connect
Subscribe

Overview

Why PPH

  • Highly Liquid Companies: Tracks the largest most liquid pharmaceutical companies
  • Industry Leaders: Favors established industry leaders with meaningful scale
  • Global Scope: Provides exposure to U.S. and international equities for global industry representation  

Performance

Performance History:

Average Annual Total Returns* (%)

View All ETFs View All Indices
  1 MO 3 MO YTD 1 YR 3 YR 5 YR 10 YR LIFE
12/20/11
PPH (NAV) 3.54 15.75 3.54 22.46 13.13 11.48 7.90 10.21
PPH (Share Price) 3.53 15.77 3.53 22.58 13.16 11.47 7.94 10.28
MVPPHTR (Index) 3.52 15.75 3.52 22.13 12.69 11.10 7.67 10.02
Performance Differential (NAV - Index) 0.02 -- 0.02 0.33 0.44 0.38 0.23 0.19
  1 MO 3 MO YTD 1 YR 3 YR 5 YR 10 YR LIFE
12/20/11
PPH (NAV) 0.86 14.97 21.92 21.92 12.11 11.34 6.74 10.00
PPH (Share Price) 0.95 15.00 22.03 22.03 12.14 11.34 6.73 10.08
MVPPHTR (Index) 0.89 15.01 21.58 21.58 11.64 10.88 6.49 9.81
Performance Differential (NAV - Index) -0.03 -0.04 0.34 0.34 0.47 0.46 0.25 0.19

*Returns less than one year are not annualized.

The performance data quoted represents past performance. Past performance is not a guarantee of future results. Investment return and principal value of an investment will fluctuate so that an investor's shares, when redeemed, may be worth more or less than their original cost. Performance may be lower or higher than performance data quoted. Please call 800.826.2333 or visit vaneck.com for performance current to the most recent month ended.

Prices as of 02/27/2026

NAV/
Market
Price 		Volume
30-Day Avg./
Last Trading Day 		Daily Change
NAV/
Last Price 		YTD Change NAV/
Last Price 		Premium/
Discount 		30-Day
Median
Bid Ask
Spread 		NAV
Chart
PPH $111.70
$111.70 		449,351
76,852 		$2.21 / +2.02%
$2.20 / +2.01% 		+8.32%
+8.27% 		$0.00
0.00% 		0.04%

Fees

Holdings

Daily Holdings (%) as of 02/26/2026

Download XLS Get holdings
Total Holdings: 26
Ticker
 Holding Name % of Net
Assets
Identifier (FIGI)
Shares
 Asset Class Market Value
(US$) 		Notional Value
LLY US
 Eli Lilly & Co 18.68
BBG000BNBDC2
234,856
 Stock 240,027,529 --
NVS US
 Novartis Ag 11.39
BBG000LYF3S8
884,296
 Stock 146,359,831 --
MRK US
 Merck & Co Inc 9.53
BBG000BPD168
1,026,496
 Stock 122,460,973 --
GSK US
 Gsk Plc 4.90
BBG000BLB481
1,084,608
 Stock 62,983,187 --
MCK US
 Mckesson Corp 4.90
BBG000DYGNW7
64,578
 Stock 62,928,032 --
BMY US
 Bristol-Myers Squibb Co 4.87
BBG000DQLV23
1,025,301
 Stock 62,645,891 --
JNJ US
 Johnson & Johnson 4.82
BBG000BMHYD1
254,214
 Stock 61,893,483 --
PFE US
 Pfizer Inc 4.77
BBG000BR2B91
2,262,977
 Stock 61,326,677 --
AZN US
 Astrazeneca Plc 4.54
BBG000D3MHB4
285,797
 Stock 58,296,872 --
NVO US
 Novo Nordisk A/S 4.50
BBG000BQBKR3
1,538,849
 Stock 57,891,499 --
SNY US
 Sanofi Sa/France 4.09
BBG000BBD5N1
1,087,978
 Stock 52,603,736 --
ABBV US
 Abbvie Inc 4.08
BBG0025Y4RY4
233,164
 Stock 52,389,619 --
COR US
 Cencora Inc 4.07
BBG000MDCQC2
142,503
 Stock 52,248,725 --
ZTS US
 Zoetis Inc 3.39
BBG0039320N9
335,993
 Stock 43,598,452 --
HLN US
 Haleon Plc 3.02
BBG018GZNCH6
3,602,284
 Stock 38,760,576 --
TAK US
 Takeda Pharmaceutical Co Ltd 2.90
BBG000LF8708
2,011,813
 Stock 37,278,895 --
TEVA US
 Teva Pharmaceutical Industries Ltd 2.66
BBG000C0CD58
1,013,000
 Stock 34,209,010 --
VTRS US
 Viatris Inc 0.86
BBG00Y4RQNH4
728,219
 Stock 11,105,340 --
JAZZ US
 Jazz Pharmaceuticals Plc 0.66
BBG000G9CGL0
45,191
 Stock 8,539,743 --
ELAN US
 Elanco Animal Health Inc 0.47
BBG00LJYS1P8
230,989
 Stock 6,049,602 --
AXSM US
 Axsome Therapeutics Inc 0.42
BBG00B6G7GL7
32,816
 Stock 5,355,243 --
CORT US
 Corcept Therapeutics Inc 0.17
BBG000BKJG33
59,662
 Stock 2,134,706 --
OGN US
 Organon & Co 0.10
BBG00ZQRGW24
183,713
 Stock 1,328,245 --
BHC US
 Bausch Health Cos Inc 0.09
BBG000DLFM21
193,097
 Stock 1,166,306 --
PRGO US
 Perrigo Co Plc 0.08
BBG000CNFQW6
74,220
 Stock 1,053,182 --
-USD CASH-
 -0.00
--
-9,015
 Cash Bal -9,015 --
--
Other/Cash 0.04
--
0
 Cash 554,455 --
← Scroll for more information →
These are not recommendations to buy or to sell any security. Securities and holdings may vary.

Portfolio

Sector Weightings (%) as at 01/31/2026

  • Sector

    % of Net Assets

  • Health Care

    99.80

  • Other/Cash

    0.20

Country Weightings (%) as at 01/31/2026

  • Country

    % of Net Assets

  • United States

    60.80

  • United Kingdom

    11.69

  • Switzerland

    10.46

  • Denmark

    7.28

  • France

    4.07

  • Japan

    2.76

  • Israel

    2.75

  • Other/Cash

    0.20

Distributions

Yields  as of  02/27/2026

Distribution Frequency

Quarterly

30-Day SEC Yield

1.83%

Distribution Yield

1.11%

12 Month Yield

1.64%

Yield information reflects temporary waivers of expenses and/or fees. Yields would have been reduced had these fees/expenses been included. In the absence of temporary expense waivers or reimbursements, the 30-Day SEC Yield for VanEck Pharmaceutical ETF would have been 1.83% on 02/27/26. Distributions may vary from time to time.

Team

Literature

PPH